The Global Market for Next-Generation Natural Fibers 2026-2036 provides comprehensive analysis and forecasts for the rapidly expanding sustainable materials sector, covering plant ...
The market is in the Late Maturity stage, functioning as a stable, consolidated "Cash Cow." Growth is now driven by ...
According to MarketsandMarkets™, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion by 2031, at a CAGR of 35.2%.
According to MarketsandMarkets, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion ...
3don MSN
Commercially viable biomanufacturing: Designer yeast turns sugar into lucrative chemical 3-HP
Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...
According to MarketsandMarketstm, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion by 2031, at a CAGR of 35.2%. Browse 250 market data ...
Xanthan gum is a microbial exopolysaccharide produced primarily through the fermentation of Xanthomonas campestris. Its exceptional rheological properties have established it as a vital component in a ...
Achieved ethanol yields exceeding guaranteed performance for over 14 consecutive days at steady stateSuccessfully operated on complex syngas ...
In its five years, Aqua Cultured Foods had some success developing whole-cut, fish-free seafood, including tuna, scallops and ...
A new study tests whether spent yeast from breweries can supply cellulose scaffolds that support lab-grown meat production.
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback